Study S001542

Exenatide in Extreme Pediatric Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01237197
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 26
Start: 2010-10
Primary completion: 2012-05
Lead sponsor: University of Minnesota
Conditions: Obesity
Interventions: DRUG:Exenatide; DRUG:Placebo
Results posted: TRUE

Registered primary outcomes

Percent Change From Baseline in Body Mass Index at 3-months [Baseline and 3-months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0013363	The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial. Kelly AS, JAMA pediatrics	2013	Randomized trial	PMID 23380890 DOI	cites ClinicalTrials.gov:NCT01237197; registry reference DERIVED:23380890